Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Isocitratdehydrogenase 1 (IDH1) (MUT) Inhibitors & Acute myeloid leukemia (AML) (IDH1 m)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

For Acute myeloid leukemia (AML) (IDH1 m), there are specific Isocitratdehydrogenase 1 (IDH1) (MUT) Inhibitors treatments available. The main drugs used in clinical settings are ivosidenib and olutasidenib.
Megías-Vericat et al. 2019 Blood Lymphat Cancer 9: 19-32
Dai et al. 2026 Chem Biodivers 23(2): e03194

…

IDH1-mutated relapsed or refractory AML: current challenges and future prospects
Megías-Vericat et al. 2019 Blood Lymphat Cancer 9: 19-32
Review
Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukemia
Dai et al. 2026 Chem Biodivers 23(2): e03194
Review

7/1/2026